A MYC–GCN2–eIF2α negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer
- 4 November 2019
- journal article
- research article
- Published by Springer Nature in Nature Cell Biology
- Vol. 21 (11) , 1413-1424
Abstract
Tumours depend on altered rates of protein synthesis for growth and survival, which suggests that mechanisms controlling mRNA translation may be exploitable for therapy. Here, we show that loss of APC, which occurs almost universally in colorectal tumours, strongly enhances the dependence on the translation initiation factor eIF2B5. Depletion of eIF2B5 induces an integrated stress response and enhances translation of MYC via an internal ribosomal entry site. This perturbs cellular amino acid and nucleotide pools, strains energy resources and causes MYC-dependent apoptosis. eIF2B5 limits MYC expression and prevents apoptosis in APC-deficient murine and patient-derived organoids and in APC-deficient murine intestinal epithelia in vivo. Conversely, the high MYC levels present in APC-deficient cells induce phosphorylation of eIF2α via the kinases GCN2 and PKR. Pharmacological inhibition of GCN2 phenocopies eIF2B5 depletion and has therapeutic efficacy in tumour organoids, which demonstrates that a negative MYC–eIF2α feedback loop constitutes a targetable vulnerability of colorectal tumours.Keywords
This publication has 68 references indexed in Scilit:
- The ribosome profiling strategy for monitoring translation in vivo by deep sequencing of ribosome-protected mRNA fragmentsNature Protocols, 2012
- Comprehensive molecular characterization of human colon and rectal cancerNature, 2012
- A unifying model for mTORC1-mediated regulation of mRNA translationNature, 2012
- MYC on the Path to CancerCell, 2012
- RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemiaNature, 2011
- Functional Identification of Optimized RNAi Triggers Using a Massively Parallel Sensor AssayMolecular Cell, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Distinct Thresholds Govern Myc's Biological Output In VivoCancer Cell, 2008
- Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiencyNature, 2008
- Oncogenic pathway signatures in human cancers as a guide to targeted therapiesNature, 2005